LANREOTIDE for Off label use: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 429 adverse event reports in the FDA FAERS database where LANREOTIDE was used for Off label use.
Most Reported Side Effects for LANREOTIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 1,646 | 18.3% | 66 | 418 |
| Off label use | 1,536 | 17.1% | 277 | 470 |
| Death | 1,177 | 13.1% | 1,177 | 215 |
| Fatigue | 1,022 | 11.4% | 44 | 307 |
| Nausea | 775 | 8.6% | 36 | 252 |
| Abdominal pain | 662 | 7.4% | 70 | 288 |
| Injection site pain | 618 | 6.9% | 21 | 105 |
| Malaise | 520 | 5.8% | 44 | 222 |
| Headache | 515 | 5.7% | 11 | 126 |
| Asthenia | 483 | 5.4% | 67 | 218 |
| Vomiting | 468 | 5.2% | 46 | 258 |
| Pain | 451 | 5.0% | 35 | 179 |
| Dizziness | 441 | 4.9% | 12 | 144 |
| Weight decreased | 430 | 4.8% | 43 | 208 |
| Injection site mass | 400 | 4.4% | 12 | 72 |
Other Indications for LANREOTIDE
Neuroendocrine tumour (2,629)
Acromegaly (1,956)
Product used for unknown indication (1,419)
Gastroenteropancreatic neuroendocrine tumour disease (586)
Carcinoid syndrome (581)
Carcinoid tumour (496)
Carcinoid tumour of the small bowel (298)
Pancreatic neuroendocrine tumour (232)
Gigantism (112)
Pancreatic carcinoma (85)
Other Drugs Used for Off label use
LENALIDOMIDE (5,767)
ECULIZUMAB (3,550)
CERTOLIZUMAB PEGOL (2,256)
ABOBOTULINUMTOXINA (2,170)
LEVETIRACETAM (2,161)
APREMILAST (1,995)
PROPRANOLOL (1,576)
CETIRIZINE (1,416)
HUMAN IMMUNOGLOBULIN G (1,129)
THALIDOMIDE (1,033)